Vaccine News and Research

Latest Vaccine News and Research

EC approves Pfizer’s Prevenar 13 to prevent pneumococcal disease

Pfizer Inc. announced today that the European Commission has approved expanding the use of the company's pneumococcal conjugate vaccine, Prevenar 13(pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), to older children and adolescents aged 6 to 17 years for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumoniae.

9 Jan 2013

SNSF-funded professor to receive 2012 National Latsis Prize

On 10 January 2013, Jacques Fellay will receive the National Latsis Prize 2012 at the Rathaus in Berne. The Swiss National Science Foundation (SNSF) is awarding the Prize to the SNSF-funded professor at EPF Lausanne in recognition of his work on the human genome and its defence mechanisms against viral diseases such as AIDS.

8 Jan 2013

Adolescents may lose hepatitis B virus protection despite vaccination as infants

New research reveals that a significant number of adolescents lose their protection from hepatitis B virus (HBV) infection, despite having received a complete vaccination series as infants. Results in the January 2013 issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, suggest teens with high-risk mothers (those positive for HBeAg) and teens whose immune system fails to remember a previous viral exposure (immunological memory) are behind HBV reinfection.

8 Jan 2013

Study shows timely reminders increase immunization rates among preschool children

New research from the Children's Outcomes Research Program at Children's Hospital Colorado shows that timely reminders by state or local health departments are more effective at increasing immunization rates among preschool children than those from primary care practices.

8 Jan 2013

Vaccine gives HIV patients a long-term boost

A functional cure for HIV-1 seems feasible after research shows that an immunotherapeutic vaccine demonstrated long-term efficacy at reducing viral load when administered to patients in the early stages of disease.

7 Jan 2013

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA’s review to be completed in the first half of 2013.

7 Jan 2013

Editorial, opinion pieces address effects of health worker murders in Pakistan on polio eradication

Several news outlets published opinion pieces regarding the recent murders of polio vaccination and other aid workers in Pakistan.

7 Jan 2013

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.

7 Jan 2013

Experts question proposed mercury preservative ban in vaccines

A ban on the use of a mercury-based preservative in vaccines tabled by the United Nations Environmental Program should be struck from a draft treaty as it may severely affect access to vaccines, experts urge.

4 Jan 2013

Report shows how P. gingivalis manipulates body's immune system to disable normal processes

A new research report published in the Journal of Leukocyte Biology shows how the bacteria known for causing gum disease--Porphyromonas gingivalis--manipulates the body's immune system to disable normal processes that would otherwise destroy it. Specifically, the report shows that this pathogen prompts the production of the anti-inflammatory molecule Interleukin-10 (IL-10).

4 Jan 2013

Pakistan records 306 measles cases in 2012, compared with 64 in 2011, WHO reports

"Measles cases surged in Pakistan in 2012, and hundreds of children died from the disease, an international health body said Tuesday," the Associated Press/CBS News reports. "A spokeswoman for the World Health Organization, Maryam Yunus, said that 306 children died in Pakistan of measles in 2012, compared to 64 the year before," the news agency writes.

4 Jan 2013

CXCR5 molecule effectively polices lung tuberculosis and prevents deadly infection

The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine.

3 Jan 2013

Opinion pieces, editorial address murders of polio workers in Pakistan

Several newspapers published opinion pieces regarding the recent murders of polio vaccination workers in Pakistan.

3 Jan 2013

Adrenomed creates Adrecizumab to decrease death rates from sepsis

The German corporation Adrenomed AG today announced its intentions to contribute to the reduction of mortality from sepsis and septic shock. Sepsis is an advanced systemic infection that travels via the blood stream to many of the body's vital organs, which can lead to death and disability.

3 Jan 2013

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

"Thanks to a herculean effort by health advocates, 78 percent of children in low-income countries receive the basic set of childhood vaccines, covering diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenza," a Bloomberg View editorial states.

3 Jan 2013

Soligenix's OrbeShield granted FDA oral BDP orphan drug designation

Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.

2 Jan 2013

Insights into tissue-based T cells

US researchers have, for the first time, characterized T cells located in human tissues, rather than in the blood.

31 Dec 2012

Uncharacterized TLR plays key role in Toxoplasma gondii response

A previously uncharacterized toll-like receptor appears to play a crucial role in the innate immune response to Toxoplasma gondii infection and may promote host resistance, potentially leading to anti-parasite vaccines, say US researchers.

28 Dec 2012

Immune-promoting drugs may control recurrent disease

Nearly half of the 700,000 cancer patients who undergo surgical removal of a primary tumor each year suffer a recurrence of their disease at some point, and many of those patients will eventually die from their disease.

28 Dec 2012

Gates Foundation grant to promote effective use of new cholera vaccine

The Johns Hopkins Bloomberg School of Public Health was awarded a four-year, $5 million grant from the Bill & Melinda Gates Foundation to promote the effective use of oral cholera vaccine around the world. The Delivering Oral Vaccine Effectively (DOVE) program will provide relief agencies and governments with technical assistance on how to use oral cholera vaccine, evaluate current vaccine-use practices and develop new field surveillance methods for monitoring and controlling outbreaks of the disease.

28 Dec 2012

Vaccine News and Research

Latest Vaccine News and Research

EC approves Pfizer’s Prevenar 13 to prevent pneumococcal disease

SNSF-funded professor to receive 2012 National Latsis Prize

Adolescents may lose hepatitis B virus protection despite vaccination as infants

Study shows timely reminders increase immunization rates among preschool children

Vaccine gives HIV patients a long-term boost

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Editorial, opinion pieces address effects of health worker murders in Pakistan on polio eradication

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

Experts question proposed mercury preservative ban in vaccines

Report shows how P. gingivalis manipulates body's immune system to disable normal processes

Pakistan records 306 measles cases in 2012, compared with 64 in 2011, WHO reports

CXCR5 molecule effectively polices lung tuberculosis and prevents deadly infection

Opinion pieces, editorial address murders of polio workers in Pakistan

Adrenomed creates Adrecizumab to decrease death rates from sepsis

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

Soligenix's OrbeShield granted FDA oral BDP orphan drug designation

Insights into tissue-based T cells

Uncharacterized TLR plays key role in Toxoplasma gondii response

Immune-promoting drugs may control recurrent disease

Gates Foundation grant to promote effective use of new cholera vaccine

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in